Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /

Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / / Edited by Veysel Kayser.

Show other versions (1)

The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each p...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Kayser, Veysel,
Place / Publishing House:Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022.
©2022
Year of Publication:2022
Language:English
Physical Description:1 online resource (298 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603384804498
ctrlnum (CKB)5400000000045940
(NjHacI)995400000000045940
(EXLCZ)995400000000045940
collection bib_alma
record_format marc
spelling Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Edited by Veysel Kayser.
Basel : MDPI - Multidisciplinary Digital Publishing Institute, 2022.
©2022
1 online resource (298 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on: online resource; title from PDF information screen (directory.doabooks.org, viewed June 25, 2023).
The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.
Includes bibliographical references and index.
Pharmaceutical industry.
3-0365-2687-0
Kayser, Veysel, editor.
language English
format eBook
author2 Kayser, Veysel,
author_facet Kayser, Veysel,
author2_variant v k vk
author2_role TeilnehmendeR
title Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
spellingShingle Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
title_full Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Edited by Veysel Kayser.
title_fullStr Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Edited by Veysel Kayser.
title_full_unstemmed Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers / Edited by Veysel Kayser.
title_auth Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
title_new Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
title_sort therapeutic monoclonal antibodies and antibody products, their optimization and drug design in cancers /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2022
physical 1 online resource (298 pages)
isbn 3-0365-2687-0
callnumber-first H - Social Science
callnumber-subject HD - Industries, Land Use, Labor
callnumber-label HD9665
callnumber-sort HD 49665.5 T447 42022
illustrated Not Illustrated
dewey-hundreds 300 - Social sciences
dewey-tens 330 - Economics
dewey-ones 338 - Production
dewey-full 338.476151
dewey-sort 3338.476151
dewey-raw 338.476151
dewey-search 338.476151
work_keys_str_mv AT kayserveysel therapeuticmonoclonalantibodiesandantibodyproductstheiroptimizationanddrugdesignincancers
status_str n
ids_txt_mv (CKB)5400000000045940
(NjHacI)995400000000045940
(EXLCZ)995400000000045940
carrierType_str_mv cr
is_hierarchy_title Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /
author2_original_writing_str_mv noLinkedField
_version_ 1796653217974583297
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01740nam a2200325 i 4500</leader><controlfield tag="001">993603384804498</controlfield><controlfield tag="005">20230625200151.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230625s2022 sz ob 001 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000045940</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000045940</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000045940</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">HD9665.5</subfield><subfield code="b">.T447 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">338.476151</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers /</subfield><subfield code="c">Edited by Veysel Kayser.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2022</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (298 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (directory.doabooks.org, viewed June 25, 2023).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The book broadly deals with therapeutic monoclonal antibodies (mAbs) and various relevant topics, including different antibody formats such as Antibody-Drug Conjugates (ADC), bispecifics, nanoparticle-based mAbs and HER2+ cancers, immune checkpoint inhibitors and other closely related topics. Each paper was written by leading active research groups in their fields both from academia and industry. The book should be of interest to those scientists and researchers who develop or use biologics, biotherapeutics, biosimilars and biobetters in cancer treatment.</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical industry.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2687-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kayser, Veysel,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-06 03:29:59 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338132750004498&amp;Force_direct=true</subfield><subfield code="Z">5338132750004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338132750004498</subfield></datafield></record></collection>

Similar Items